Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Transmembrane channel-like protein 1 is a mechanosensitive ion channel localized to cochlear hair cells, where it forms the ion-conducting pore of the mechanoelectrical transducer (MET) channel critical for sound detection. TMC1 assembles as a dimer with each subunit containing 10 transmembrane helices, forming a structure similar to TMEM16 and OSCA family channels. Mutations disrupting pore function reduce calcium permeability, trigger apoptosis of auditory hair cells, and lead to congenital or progressive hearing loss in humans and mice. TMC1 is mechanistically involved in the initial step of sensory transduction by gating in response to mechanical force delivered by tip links in hair cells, thus converting sound waves into electrical signals. Accessory proteins (e.g., TMIE, LHFPL5) help localize and regulate TMC1 at the stereocilia tips.
For gene therapy: Restoration of TMC1 function in cochlear hair cells to recover auditory transduction. For mechanosensitive channel modulators: Hypothetical modulation of channel gating (not yet established drugs).
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Transmembrane channel-like protein 1 (TMC1).